Table 4.
Novel mortality prediction models for ALF-patients receiving ECMO support
| Coefficient | OR | 95% CI | |
|---|---|---|---|
|
Model 1 (pre-ECMO) |
|
|
|
| Age (per five years) |
0.176 |
1.193 |
(1.148 to 1.239) |
| Immunocompromised state |
0.958 |
2.605 |
(1.316 to 5.158) |
| Minute ventilation (L/minute) |
0.098 |
1.103 |
(1.014 to 1.199) |
| Pre-ECMO hemoglobin (g/dL) |
-0.182 |
0.834 |
(0.728 to 0.954) |
| Pre-ECMO lactate (mmol/L) |
0.013 |
1.013 |
(1.004 to 1.023) |
| Intercept |
-2.083 |
|
|
|
Model 2 (Day 1) |
|
|
|
| Age (per five years) |
0.184 |
1.202 |
(1.148 to 1.258) |
| Immunocompromised state |
1.093 |
2.984 |
(1.394 to 6.391) |
| Minute ventilation (L/minute) |
0.137 |
1.147 |
(1.030 to 1.276) |
| Pre-ECMO hemoglobin (g/dL) |
-0.208 |
0.812 |
(0.696 to 0.947) |
| Day 1 FiO2 (per 10%) |
0.264 |
1.302 |
(1.232 to 1.376) |
| Day 1 fibrinogen (mg/dL) |
-0.002 |
0.998 |
(0.996 to 0.999) |
| Day 1 norepinephrine (μg/minute/10 kg) |
0.159 |
1.172 |
(0.980 to 1.401) |
| Day 1 C-reactive protein (mg/L) |
-0.004 |
0.996 |
(0.992 to 0.999) |
| Intercept | -1.893 |
ALF, acute lung failure; CI, confidence interval; ECMO, extracorporeal membrane oxygenation; FiO2, fraction of inspired oxygen; OR, odds ratio.